The Dual Mechanistic Actions of Natural Compounds CAPE and EGCG Targeting VEGF and PI3K/Akt/mTOR Pathways in Lung Cancer
DOI:
https://doi.org/10.58600/eurjther2982Keywords:
EGCG, CAPE, VEGF, PI3K/Akt/mTOR, signaling pathwayAbstract
Objective: Lung cancer is characterized by uncontrolled proliferation, loss of apoptosis, angiogenesis, and metastatic potential. Caffeic acid phenethyl ester (CAPE), the major bioactive molecule of propolis, and epigallocatechin gallate (EGCG), a essential polyphenol of green tea, have documented antioxidant, anti-proliferative, and anti-angiogenic effects. This study aimed to investigate the effects of EGCG and CAPE on VEGF and the PI3K/Akt/mTOR signaling pathway, key regulators of lung cancer progression, using in silico and in vitro models.
Methods: This study Lung cancer cells (DSMZ/ACC-234) was conducted to demonstrate the inhibition of cell proliferation by the MTT method, molecular binding via autodock vina and protein expression by immunohistochemistry analysis, targeting the VEGF and PI3K/Akt/mTOR pathways with CAPE and EGCG treatment.
Results: EGCG and CAPE treatments significantly reduced cell proliferation in lung cancer cells. Untreated cells exhibited strong to very strong immunoreactivity for VEGF and PI3K/Akt/mTOR pathway markers, whereas EGCG reduced these signals to mild–moderate levels and to CAPE moderate–strong levels. Since both treatments resulted in a statistically significant increase in mTORC1 immunoreactivity, molecular docking targeting was performed via it.
Conclusion: EGCG and CAPE exhibit significant anti-proliferative and anti-angiogenic effects by adjusting the VEGF and PI3K/Akt/mTOR signaling pathways in lung cancer cells. mTORC1 activation molecular binding affinity is higher in the CAPE-treated group compared to the EGCG group. These findings highlight the therapeutic importance of targeting these pathways in developing novel treatment strategies for lung cancer.
References
[1] Jemal A, Miller KD, Ma J, Siegel RL, Fedewa SA, Islami F, Devesa SS, Thun MJ (2018) Higher Lung Cancer Incidence in Young Women Than Young Men in the United States. N Engl J Med. 378(21):1999-2009. https://doi.org/10.1056/NEJMoa1715907
[2] Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature. 553(7689):446-54. https://doi.org/10.1038/nature25183
[3] De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F (2019) Radiotherapy toxicity. Nature Reviews Disease Primers. 5(1):13. https://doi.org/10.1038/s41572-019-0064-5
[4] Granton PV, Dubois L, van Elmpt W, van Hoof SJ, Lieuwes NG, De Ruysscher D, Verhaegen F (2014) A longitudinal evaluation of partial lung irradiation in mice by using a dedicated image-guided small animal irradiator. Int J Radiat Oncol Biol Phys. 90(3):696-704. https://doi.org/10.1016/j.ijrobp.2014.07.004
[5] Suzuki-Chiba H, Konishi T, Aso S, Makito K, Matsui H, Jo T, Fushimi K, Yasunaga H (2024) Comparison of olanzapine 2.5 mg and 5 mg in the prevention of chemotherapy-induced nausea and vomiting: a Japanese nationwide database study. Int J Clin Oncol. 29(11):1762-73. ttps://doi.org/10.1007/s10147-024-02603-2
[6] Ohmori T, Yamaoka T, Ando K, Kusumoto S, Kishino Y, Manabe R, Sagara H (2021) Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury. Int J Mol Sci. 22(2). https://doi.org/10.3390/ijms22020792
[7] Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, Mukherjee A, Paul MK (2023) Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 22(1):40. https://doi.org/10.1186/s12943-023-01740-y
[8] Pandey P, Khan F, Upadhyay TK, Giri PP (2023) Therapeutic efficacy of caffeic acid phenethyl ester in cancer therapy: An updated review. Chem Biol Drug Des. 102(1):201-16. https://doi.org/10.1111/cbdd.14233
[9] Chu J, Zhang X, Jin L, Chen J, Du B, Pang Q (2015) Protective effects of caffeic acid phenethyl ester against acute radiation-induced hepatic injury in rats. Environ Toxicol Pharmacol. 39(2):683-9. https://doi.org/10.1016/j.etap.2015.01.020
[10] Lee Y, Shin DH, Kim JH, Hong S, Choi D, Kim YJ, Kwak MK, Jung Y (2010) Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition. Eur J Pharmacol. 643(1):21-8. https://doi.org/10.1016/j.ejphar.2010.06.016
[11] Yang N, Shi JJ, Wu FP, Li M, Zhang X, Li YP, Zhai S, Jia XL, Dang SS (2017) Caffeic acid phenethyl ester up-regulates antioxidant levels in hepatic stellate cell line T6 via an Nrf2-mediated mitogen activated protein kinases pathway. World J Gastroenterol. 23(7):1203-14. https://doi.org/10.3748/wjg.v23.i7.1203
[12] Bimonte S, Cascella M, Barbieri A, Arra C, Cuomo A (2020) Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge. Infect Agent Cancer. 15:2. https://doi.org/10.1186/s13027-020-0270-5
[13] Kciuk M, Alam M, Ali N, Rashid S, Glowacka P, Sundaraj R, Celik I, Yahya EB, Dubey A, Zerroug E, Kontek R (2023) Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. Molecules. 28(13). https://doi.org/10.3390/molecules28135246
[14] Talib WH, Awajan D, Alqudah A, Alsawwaf R, Althunibat R, Abu AlRoos M, Al Safadi A, Abu Asab S, Hadi RW, Al Kury LT (2024) Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets. Molecules. 29(6). https://doi.org/10.3390/molecules29061373
[15] Liu S, Xu ZL, Sun L, Liu Y, Li CC, Li HM, Zhang W, Li CJ, Qin W (2016) (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN. Mol Med Rep. 14(1):599-605. https://doi.org/10.3892/mmr.2016.5277
[16] Zhang X, Huang H, Sun S, Li D, Sun L, Li Q, Chen R, Lai X, Zhang Z, Zheng X, Wong WL, Wen S (2022) Induction of Apoptosis via Inactivating PI3K/AKT Pathway in Colorectal Cancer Cells Using Aged Chinese Hakka Stir-Fried Green Tea Extract. Molecules. 27(23). https://doi.org/10.3390/molecules27238272
[17] Okkenhaug K, Graupera M, Vanhaesebroeck B (2016) Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy. Cancer Discov. 6(10):1090-105. https://doi.org/10.1158/2159-8290.CD-16-0716
[18] Murillo MM, Zelenay S, Nye E, Castellano E, Lassailly F, Stamp G, Downward J (2025) Corrigendum to RAS interaction with PI3K p110alpha is required for tumor-induced angiogenesis. J Clin Invest. 135(16). https://doi.org/10.1172/JCI197925
[19] Lin CL, Chen RF, Chen JY, Chu YC, Wang HM, Chou HL, Chang WC, Fong Y, Chang WT, Wu CY, Chiu CC (2012) Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-kappaB pathway. Int J Mol Sci. 13(5):6236-45. https://doi.org/10.3390/ijms13056236
[20] Klinski E, Semov A, Yan X, Alakhov V, Muyzhnek E, Kiselev V (2013) Block copolymer based composition of epigallocatechin-3-gallate with improved oral bioavailability as a way to increase its therapeutic activity. J Nanomed Biother Discov. 3:117. https://doi.org/10.4172/2155-983X.1000117
[21] Karadeniz T, Cavusoğlu T, Turkmen E, Uyanıkgil Y, Karadeniz M, Akdemir O, Tuglu MI, Ates U, Erbas O (2014) Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy. Renal Failure. 36(8):1283-90. https://doi.org/10.3109/0886022X.2014.930331
[22] Liu Y, Yang X, Gan J, Chen S, Xiao Z-X, Cao Y (2022) CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic acids research. 50(W1):W159-W64. https://doi.org/10.1093/nar/gkac394
[23] Rao T, Tan Z, Peng J, Guo Y, Chen Y, Zhou H, Ouyang D (2019) The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective. Pharmacol Res. 146:104283. https://doi.org/10.1016/j.phrs.2019.104283
[24] Khair AMB, Maniangat Luke A, Patnaik R, Testarelli L (2025) EGCG’s anticancer potential unveiled: triggering apoptosis in lung cancer cell lines through in vitro investigation. PeerJ. 13:e19135. https://doi.org/10.7717/peerj.19135
[25] Ozturk G, Ginis Z, Akyol S, Erden G, Gurel A, Akyol O (2012) The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers. Eur Rev Med Pharmacol Sci. 16(15):2064-8.
[26] Twum Y, Marshall K, Gao W (2023) Caffeic acid phenethyl ester surmounts acquired resistance of AZD9291 in non-small cell lung cancer cells. Biofactors. 49(6):1143-57. https://doi.org/10.1002/biof.1983
[27] Lee CY, Fu YK, Yeh CC, Kuo LK, Kuo YY, Huo C, Lee SW, Huang YC, Shih LJ, Li CY, Huang SP, Lai CJ, Chuu CP (2025) Combined Treatment of Cisplatin With Caffeic Acid Phenethyl Ester Demonstrates Additive Growth Inhibition on Non-small Cell Lung Cancer Cells. Anticancer Res. 45(11):4971-86. https://doi.org/10.21873/anticanres.17840
[28] Chung TW, Kim SJ, Choi HJ, Kwak CH, Song KH, Suh SJ, Kim KJ, Ha KT, Park YG, Chang YC, Chang HW, Lee YC, Kim CH (2013) CAPE suppresses VEGFR-2 activation, and tumor neovascularization and growth. J Mol Med (Berl). 91(2):271-82. https://doi.org/10.1007/s00109-012-0952-6
[29] Burdett S, Pignon JP, Tierney J, Tribodet H, Stewart L, Le Pechoux C, Auperin A, Le Chevalier T, Stephens RJ, Arriagada R, Higgins JP, Johnson DH, Van Meerbeeck J, Parmar MK, Souhami RL, Bergman B, Douillard JY, Dunant A, Endo C, Girling D, Kato H, Keller SM, Kimura H, Knuuttila A, Kodama K, Komaki R, Kris MG, Lad T, Mineo T, Piantadosi S, Rosell R, Scagliotti G, Seymour LK, Shepherd FA, Sylvester R, Tada H, Tanaka F, Torri V, Waller D, Liang Y, Non-Small Cell Lung Cancer Collaborative G (2015) Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. Cochrane Database Syst Rev. 2015(3):CD011430. https://doi.org/10.1002/14651858.CD011430
[30] Shi S, Xu J, Zhang B, Ji S, Xu W, Liu J, Jin K, Liang D, Liang C, Liu L, Liu C, Qin Y, Yu X (2016) VEGF Promotes Glycolysis in Pancreatic Cancer via HIF1alpha Up-Regulation. Curr Mol Med. 16(4):394-403. https://doi.org/10.2174/1566524016666160316153623
[31] Wei R, Hackman RM, Wang Y, Mackenzie GG (2019) Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts. Cancers (Basel). 11(10). https://doi.org/10.3390/cancers11101496
[32] Yahya S, Sulaiman MK, Sudhandiran G (2024) Caffeic acid phenethyl ester mediates apoptosis in serum-starved HT29 colon cancer cells through modulation of heat shock proteins and MAPK pathways. Cell Biochem Funct. 42(2):e3942. https://doi.org/10.1002/cbf.3942
[33] Van Aller GS, Carson JD, Tang W, Peng H, Zhao L, Copeland RA, Tummino PJ, Luo L (2011) Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochem Biophys Res Commun. 406(2):194-9. https://doi.org/10.1016/j.bbrc.2011.02.010
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Yağmur Dilber, Gülçin Ekizçeli, Elgin Türköz Uluer, Kemal Özbilgin, Sevinç İnan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
